FR2426055A1 - Proteine purifiee associee au cancer - Google Patents

Proteine purifiee associee au cancer

Info

Publication number
FR2426055A1
FR2426055A1 FR7912426A FR7912426A FR2426055A1 FR 2426055 A1 FR2426055 A1 FR 2426055A1 FR 7912426 A FR7912426 A FR 7912426A FR 7912426 A FR7912426 A FR 7912426A FR 2426055 A1 FR2426055 A1 FR 2426055A1
Authority
FR
France
Prior art keywords
cadet
iac
purified protein
cancer
protein associated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7912426A
Other languages
English (en)
Inventor
Kurt Baekgaard Osther
Kurt Frimann Berg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alfred Benzon AS
Original Assignee
Alfred Benzon AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfred Benzon AS filed Critical Alfred Benzon AS
Publication of FR2426055A1 publication Critical patent/FR2426055A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La présente invention a pour objet une protéine purifiée dénommée CaDet dont le test en gel incliné SDS PAGE indique un poids moléculaire d'environ 25 000 Daltons. Elle est caractérisée en ce que l'on soumet une solution contenant un composant précipitant avec des anticorps de la C1 IAC à une chromatographie par affinité pour anticorps et en ce que l'on élue la CaDet liée à l'anticorps. La CaDet réagit avec l'anti-C1 IAC dans des tests d'immunoprécipitation et lorsqu'elle est utilisée pour l'immunisation, elle fournit de plus grands titres en Anti-C1 IAC.
FR7912426A 1978-05-17 1979-05-16 Proteine purifiee associee au cancer Withdrawn FR2426055A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK216378 1978-05-17

Publications (1)

Publication Number Publication Date
FR2426055A1 true FR2426055A1 (fr) 1979-12-14

Family

ID=8110498

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7912426A Withdrawn FR2426055A1 (fr) 1978-05-17 1979-05-16 Proteine purifiee associee au cancer

Country Status (15)

Country Link
JP (1) JPS5516291A (fr)
AU (1) AU521404B2 (fr)
BE (1) BE876301A (fr)
DE (1) DE2919833A1 (fr)
ES (1) ES480624A1 (fr)
FI (1) FI791551A (fr)
FR (1) FR2426055A1 (fr)
GB (1) GB2021593A (fr)
IT (1) IT7968046A0 (fr)
LU (1) LU81273A1 (fr)
NL (1) NL7903854A (fr)
NO (1) NO791643L (fr)
NZ (1) NZ190470A (fr)
PT (1) PT69617A (fr)
SE (1) SE7904276L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO830570L (no) * 1982-02-22 1983-08-23 Carlton Med Prod Antistoffer og antigener for diagnose og behandling av cancer
AU569467B2 (en) * 1982-04-07 1988-02-04 Baylor College Of Medicine Immunoglobulin based cancer treating pharmaceutical compositions

Also Published As

Publication number Publication date
SE7904276L (sv) 1979-11-18
NO791643L (no) 1979-11-20
AU4717279A (en) 1979-11-22
GB2021593A (en) 1979-12-05
PT69617A (fr) 1979-06-01
NL7903854A (nl) 1979-11-20
BE876301A (fr) 1979-11-16
DE2919833A1 (de) 1979-11-29
NZ190470A (en) 1982-06-29
LU81273A1 (fr) 1979-09-10
JPS5516291A (en) 1980-02-04
FI791551A (fi) 1979-11-18
ES480624A1 (es) 1980-08-16
IT7968046A0 (it) 1979-05-17
AU521404B2 (en) 1982-04-01

Similar Documents

Publication Publication Date Title
O'Shannessy et al. A novel procedure for labeling immunoglobulins by conjugation to oligosaccharide moieties
Podack et al. The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum
Coulter et al. Simplified preparation of rabbit Fab fragments
Baughn et al. Characterization of the antigenic determinants and host components in immune complexes from patients with secondary syphilis.
EP0108805A1 (fr) Melanges d'anticorps monoclonaux et leur utilisation pour des analyses immunologiques a sensibilite accrue
Mihaesco et al. Papain digestion fragments of human IgM globulins
KR900013979A (ko) 사람 유두종비루스형 16의 e7 단백질상의 면역원성 영역
KR870005648A (ko) 슈도모나스 이루지노사 항원형에 대한 교차면역 반응성 및 교차보호성 단일분지계 항체
Rohde et al. Radioimmunoassay for the aminoterminal peptide of procollagen pα1 (I)-chain
East et al. On topographic antigenic determinants in myoglobins
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
Cierniewski et al. Reactivity of fibrinogen derivatives with antisera to human fibrin D-dimer and its γ-γ chain remnant
Wesierska‐Gadek et al. Autoantibodies against different histone hi subtypes in systemic lupus erythematosus sera
FR2426055A1 (fr) Proteine purifiee associee au cancer
Drbal et al. The nature of the subset of MHC class II molecules carrying the CDw78 epitopes
Duran et al. Characterization of antigenic polypeptides of the RNP, Sm and SS-B nuclear antigens from calf thymus
Bokisch et al. Isolation and immunochemical characterization of rabbit 7S anti-IgG with restricted heterogeneity
Suzuta Therapeutic and diagnostic applications of latex-bound immunoglobulins
Carding et al. Multiple proteins related to the soluble galactose-binding animal lectin revealed by a monoclonal anti-lectin antibody
DE69311796D1 (de) Peptide von dem caseinomacropeptid, antikorper dagegen und ihre andwendungen
Büsen The subunit structure of calf thymus ribonuclease H i as revealed by immunological analysis.
Warner et al. Detection of two species of antibody molecules with the same specificity
Nilsson et al. Anti-idiotypic antibodies in antisera against human C3 and factor H and their application in the enrichment of antibodies specific for H-binding domains of C3.
Aho Studies of syphilitic antibodies. II. Substances responsible for biological false positive sero-reactions.
Hori et al. Isolation and characterization of circulating immune complexes from rats with experimental membranous nephropathy.

Legal Events

Date Code Title Description
RE Withdrawal of published application